INVO Bioscience, Inc. INVO
0.83 +0.83
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 3.02M | 822.20K | 4.16M | 1.04M | 1.48M | |
| 1.09M | -28.57K | 4.02M | 948.53K | 1.34M | |
| -6.77M | -10.63M | -5.22M | -5.51M | -1.79M | |
| -8.03M | -10.89M | -6.65M | -8.35M | -2.17M | |
| -5.13 | -17.97 | -12.52 | -30.40 | -9.00 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 232.42K | 90.14K | 5.68M | 10.10M | 1.24M | |
| 20.89M | 4.10M | 10.47M | 10.95M | 1.80M | |
| 19.99M | 5.08M | 3.16M | 5.20M | 5.51M | |
| 8.29M | 2.43M | 1.90M | 752.32K | 457.47K | |
| 892.83K | -977.61K | 7.31M | 5.74M | -3.71M |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -4.76M | -6.60M | -6.03M | -4.78M | 1.37M | |
| -2.49M | -81.22K | -2.15M | -187.25K | -114.71K | |
| 7.39M | 1.09M | 3.77M | 13.82M | -229.47K | |
| -444.72K | -12.73K | -454.65K | -88.93K | -64.84K | |
| 142.29K | -5.59M | -4.41M | 8.86M | 1.03M |